Analysis | Metabolite Name | Measured Value | Units | Exercise | Group | Sex | Type |
---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 4612 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 6096 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 6147 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 6635 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 7812 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 11811 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 13338 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 13781 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 14204 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 14569 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 15798 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 16643 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 17733 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 18058 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 18137 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 19091 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 22982 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 23797 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 24517 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 26376 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 40197 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 40909 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 41858 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 42568 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 44579 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 49971 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 51174 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 51453 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 52905 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 56330 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 56607 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 57426 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 58216 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 58711 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 59300 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 59601 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 59659 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 60637 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 61800 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 63764 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 64072 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 65024 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 65477 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 65503 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 67364 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 67702 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 67746 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 68074 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 68762 | Peak area normalized | Yes | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 69133 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 69403 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 70017 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 70193 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 70403 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 70430 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 73727 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 76999 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 77865 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 78680 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 78839 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 79595 | Peak area normalized | No | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 81021 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 81410 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 81620 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 82417 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 82489 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 82730 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 84718 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 85089 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 85376 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 85755 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 87480 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 88082 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 88648 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 88961 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 90550 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 90695 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 91420 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 91682 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 92120 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 92231 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 93180 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 93351 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 93741 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 93745 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 94627 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 94815 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 95130 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 96648 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 97586 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 97622 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 98246 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 98290 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 98898 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 99694 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 100490 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 100779 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 100989 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 101341 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 101750 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 101963 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 102257 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 102739 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 102983 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 104060 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 104158 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 104466 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 105058 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 105973 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 106175 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 106439 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 106503 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 106905 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 108472 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 108787 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 109613 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 109640 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 109757 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 110345 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 110704 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 111185 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 111209 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 112146 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 113192 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 113411 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 113995 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 114513 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 114638 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 115037 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 115207 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 116501 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 118054 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 119041 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 119098 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 119135 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 119404 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 119723 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 120542 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 120787 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 120943 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 121852 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 122413 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 122797 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 123291 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 123841 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 123917 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 124225 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 124445 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 124512 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 124556 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 125068 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 125247 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 125342 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 125864 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 126256 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 126711 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 126776 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 126845 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 126950 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 127609 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 128289 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 128506 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 128568 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 129133 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 130614 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 131266 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 131321 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 131750 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 131851 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 132098 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 132489 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 132880 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 133026 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 135591 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 135855 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 135954 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 137098 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 137630 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 137838 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 138075 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 138583 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 138611 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 138849 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 139029 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 139357 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 139478 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 139674 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 140182 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 141404 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 141602 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 141640 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 142006 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 143395 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 144897 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 145852 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 146623 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 146698 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 146723 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 148573 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 149314 | Peak area normalized | Yes | PAH | Female | Cath |
Return to search page